Cargando…
Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive age-related lung disease causing relentless fibrosis of the lung parenchyma. Currently, pirfenidone and nintedanib are the two antifibrotic drugs, approved for the treatment of IPF. Both are shown to slow progression by preserv...
Autores principales: | Khan, Mohammed Ayaz, Sherbini, Nahed, Alyami, Sami, Al-Harbi, Abdullah, Al-Ghamdi, Majed, Alrajhi, Suliman, Rajendram, Rajkumar, Al-Jahdali, Hamdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034822/ https://www.ncbi.nlm.nih.gov/pubmed/36968327 http://dx.doi.org/10.4103/atm.atm_206_22 |
Ejemplares similares
-
A survival analysis of idiopathic pulmonary fibrosis in the context of antifibrotic therapy in Saudi Arabia
por: Khan, Mohammed Ayaz, et al.
Publicado: (2023) -
The effects of the COVID-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in Riyadh
por: Ayaz, Khan Mohammad, et al.
Publicado: (2021) -
Tuberculosis mortality and associated factors at King Abdulaziz Medical City Hospital
por: Aljadani, Rawabi, et al.
Publicado: (2019) -
Severe Asthma Patients Experience and Satisfaction with Virtual Clinics during COVID-19 Period
por: Khan, Mohammad Ayaz, et al.
Publicado: (2021) -
Do ward rounds offer effective teaching and training? Obstacles to learning and what makes good teaching in a large tertiary care hospital from trainee doctor’s perspective
por: Khan, Mohammad Ayaz, et al.
Publicado: (2021)